Concepedia

Meiqing Du

MD

6

Publications

532

Citations

6

H-Index

1992

Active since

Affiliations

Shengli Oilfield Central Hospital(Current)

Meiqing Du is an author at Shengli Oilfield Central Hospital specializing in hematology, immunology, and oncology.

ORCID

Top concepts

Publications per year

1992–2022

6

Publications

6

Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study.

Ralf Grunewald, Hagop M. Kantarjian, Meiqing Du et al. · Journal of Clinical Oncology · 1992 · 217 citations

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial

Han Tang, Haiming Wang, Yong Fang et al. · Annals of Oncology · 2022 · 176 citations · Full text

Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.

Varsha Gandhi, Elihu H. Estey, Meiqing Du et al. · PubMed · 1995 · 58 citations

, , +16

Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice

Meiqing Du, Xiaoyu Yang, James A. Hartman et al. · Carcinogenesis · 2012 · 56 citations · Full text

Desflurane protects against liver ischemia/reperfusion injury via regulating miR-135b-5p

Mengxia Zhong, Lei Che, Meiqing Du et al. · Journal of the Chinese Medical Association · 2020 · 14 citations · Full text

Rows per page

1–5 of 6